Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilatorassociated pneumonia).
. Founded in Argentina in 1998, the INICC is the first multinational research network established to control and reduce DA-HAIs through the analysis of data collected on a voluntary basis by a pool of hospitals worldwide. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] INICC has the following goals:
(1) to create a dynamic global network of hospitals in the developing world that conduct surveillance of DA-HAIs by means of standardized definitions and established methodologies, promote implementation of evidence-based infection control practices, and perform applied infection control research; (2) to provide training and surveillance tools to individual hospitals to allow them to conduct outcome and process surveillance of DA-HAIs, measure their consequences, and assess the impact of infection control practices; and (3) to improve the safety and quality of health care worldwide through implementation of systematized programs to reduce rates of DA-HAI-associated mortality, excess length of hospital stays, [21] [22] [23] [24] excess costs, and bacterial resistance.
METHODS
The INICC has focused on surveillance and prevention of DA-HAI in adult and pediatric ICUs and high-risk nurseries. 3, 10, 13, 25 Data are collected using standardized CDC NHSN protocols and definitions. 19, 20 The INICC's methodology includes both outcome surveillance and process surveillance components. The modules of the components may be used singly or simultaneously, but once selected, they must be used for a minimum of 1 calendar month. 3, 10, 13, 25 All DA-HAIs of the outcome surveillance component are categorized using standard CDC NHSN definitions that include laboratory and clinical criteria. 19 Both laboratory-confirmed bloodstream infection (BSIs) and clinical sepsis without microbiologic confirmation of BSI are recorded and reported. 26 Data are classified into specific module protocols addressing the following: DA-HAI rates, excess length of stay, evaluation of DA-HAI costs, crude excess mortality, microbiological profile, bacterial resistance, and antimicrobial use data within the outcome surveillance component. In addition, the INICC methodology includes a process for adjudication and validation of reported HAIs. 3, 10, 13, 25 Infection control professionals (ICPs) collect data on central line-associated primary BSIs (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated pneumonia (VAP) occurring in patients hospitalized in a specific patient care location in nearly all hospitals. ICUs are stratified according to the patient population as adult ICUs, pediatric ICUs, and neonatal ICUs (NICUs).
All NICUs are level III or level II/III units, in which ICPs collect data on CLABSIs and umbilical catheter-associated primary BSIs or VAP for each of 5 birth weight categories (<750 g, 750-1,000 g, 1,001-1,500 g, 1,501-2,500 g, >2,500 g). ICPs also collect data on corresponding denominator data, patient-days, and specific device-days.
The INICC also receives aggregated data from hospitals with previous experience in conducting surveillance of DA-HAIs. Original and aggregated data were used to calculate DA-HAI rates. Only original data were used to calculate mortality and length of stay. The process surveillance component includes the following modules: hand hygiene compliance monitoring in ICUs, central and peripheral vascular catheter care compliance monitoring, urinary catheter care compliance monitoring, monitoring of compliance with measures to prevent VAP, and performance feedback. Data from the process surveillance module on hand hygiene compliance are included in this report. 3, 10, 13, 25 The identity of all INICC hospitals, cities and countries is kept confidential, in accordance with the INICC charter. Tables 2-17.  Tables 2-7 present DA-HAI rates and DU ratios by infection type (CLABSI, CAUTI, and VAP) in adult and pediatric ICUs. The data for adult combined medical/surgical ICUs were not stratified by type or size of hospital. Device-days consisted of the total number of central line-days, urinary catheter-days, or ventilator-days. The DU ratio is an extrinsic risk factor for DA-HAI 19, 20 ; it also provides a marker for severity of illness, vis a vis patients' susceptibility to DA-HAI. Tables 8-11 present DA-HAI rates and DU ratios from the highrisk nursery component of the INICC system for CLABSIs and VAPs. For NICUs, device-days consist of the total number of central line-days, umbilical catheter-days, and ventilator-days. The data for neonatal ICUs were stratified by weight. Tables 12 and 13 provide data on crude ICU mortality in patients hospitalized in each type of unit during the surveillance period with and without DA-HAI, along with crude excess mortality of adult and pediatric patients with CLABSI, CAUTI, and VAP, and infants in NICUs with CLABSI or VAP. Tables 14 and 15 provide data on crude length of stay of patients hospitalized in each type of unit during the surveillance period with and without DA-HAI, along with crude excess length of stay of adult and pediatric patients with CLABSI, CAUTI, and VAP and infants in NICUs with CLABSI or VAP. Table 16 provides data on bacterial resistance of pathogens isolated from patients with DA-HAI in adult and pediatric ICUs and NICUs. Table 17 provides data on hand hygiene compliance in each type of unit. Tables 18 and 19 compare overall rates of CLABSI, CAUTI, and VAP (Table 18) 18 and rates of antimicrobial resistance ( 
RESULTS

DISCUSSION
The implementation effectiveness of an integrated infection control program focused on DA-HAI surveillance was demonstrated approximately 30 years ago, as shown in many studies conducted in the United States, with results indicating that the incidence of DA-HAI can be reduced by as much as 30%, and that a related reduction in health care costs was feasible as well. 28 For more than 30 years, the CDC's NNIS/NHSN network has provided benchmarking US ICU data on DA-HAIs and antibiotic resistance, which have proven to be invaluable for researchers and served as an inspiration for the INICC program. 3, 10, 13, 25 Initially, the INICC surveillance concentrated on DA-HAI surveillance in ICUs, the health care setting that has the highest DA-HAI rates and that poses the greatest risk to patient safety, given the patients' critical condition and exposure to invasive devices. 3, 10, 13 The rate of device use in the INICC ICUs is similar to or even lower than that reported in US ICUs by the NNIS/NHSN system 18 ; however, DA-HAI rates identified in INICC ICUs are significantly higher than the published US rates (Table 18) . 18, 29 Likewise, the antimicrobial resistance rates found in INICC ICUs for methicillin-resistant Staphylococcus aureus (MRSA) isolates, enterobacteria resistant to ceftazidime (extended-spectrum b-lactamase producers), and
Pseudomonas aeruginosa as resistant to fluoroquinolones were significantly higher than those reported in NHSN ICUs (Table 19) . 27 Nonetheless, the rate of vancomycin-resistant enterococci is much lower in the INICC ICUs than in the NHSN ICUs.
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These higher DA-HAI rates may reflect the typical ICU situation in limited-resources countries as a whole, and several reasons have been exposed to explain this fact. 30 Among the primary plausible causes, it can be mentioned that in almost all limited-resources countries, there are still no legally enforceable rules or regulations concerning the implementation of infection control programs, such as national infection control guidelines, and in the few countries that have such a legal framework, adherence to and compliance with the guidelines is most irregular, and hospital accreditation is not mandatory. In most INICC hospitals, a lack of official regulations is strongly correlated with considerable variability in compliance with hand hygiene recommendations. This situation is further complicated by the fact that administrative and financial support in most INICC hospitals is insufficient to fund infection control programs, 30 which invariably results in very low nurse-to-patient staffing ratiosdwhich have proven highly connected to high DA-HAI rates in ICUs 3 dhospital overcrowding, lack of medical supplies, and insufficient numbers of experienced nurses and trained health care workers.
The World Bank categorizes countries into 4 economic strata based on 2007 gross national income per capita: (1) low income, $935 or less; (2) lower middle income, $936-$3,705; (3) upper middle income, $3,706-$11,455; and (4) high income, $11,456 or more. 31 Within this categorization, 144 out of 209 countries (68%) are low-income and lower middle-income economies (also referred to as lower-income countries, low-resources countries, developing economies, or developing or emerging countries), representing more than 75% of the world's population. The relationships between DA-HAI rates and socioeconomic level (low income, middle income, or high income) and between DA-HAI rates and type of hospital (public, academic, or private) was recently published by the INICC.
32
DA-HAI surveillance is essential to reduce hospitalized patients' risk of infection, because it effectively describes and addresses the importance and characteristics of the threatening situation created by HAIs. This must be followed by the implementation of practices aimed at DA-HAI prevention and control. In addition, participation in the INICC has played a fundamental role not only in increasing the awareness of DA-HAI risks in the INICC ICUs, but also in providing an exemplar for the institution of infection control practices. In many INICC ICUs, for example, the high incidence of DA-HAI has been reduced by carrying out targeted performance feedback programs for hand hygiene and central line, mechanical ventilator, and urinary catheter care. [33] [34] [35] [36] [37] [38] [39] Finally, it is of utmost importance to restrict the administration of anti-infective agents to effectively control antibiotic resistance.
To compare a hospital's DA-HAI rates and DU ratios with the rates identified in this report, the hospital should begin data collection by applying the methods and methodology described for the NHSN and INICC, and then calculate infection rates and DU ratios for the device-associated module. The major aim of these data is to serve as a guide for the implementation of prevention strategies and other quality improvement efforts locally, to help reduce DA-HAI rates to the minimum possible level.
In conclusion, the data presented in this report underscore the fact that HAIsdparticularly DA-HAIs in ICU patients in limitedresources countriesdpose a grave and often concealed risk to patient safety. The INICC's main goal is to enhance infection control practices by facilitating elemental, feasible, and inexpensive tools and resources to tackle this problem effectively and systematically, leading to stricter adherence to infection control programs and guidelines, with a correlated reduction in DA-HAI and its adverse effects, in the ICUs participating in the INICC, as well as in all other health care facilities in the developing world. 
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